A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion

Inclusion Criteria for Cohort 1: * In good general health or medically stable. * Is able and willing to participate in, and adhere to, all testing procedures, both onsite and offsite, for the entire testing. * The participant has access to a telephone for communicating with the trial personnel and for trial personnel to contact the participant. Inclusion Criteria for Cohort 2: * In good general health or medically stable. * Has confirmed diagnosis of schizophrenia, major depressive disorder, or bipolar I disorder per Diagnostic and Statistical Manual of Mental Disorders - 5th Edition (DSM-5) criteria and currently prescribed and taking aripiprazole. * Is able and willing to participate in, and adhere to, all testing procedures, both onsite and offsite, for the entire testing. * Participant has access to a telephone for communicating with the trial personnel and for trial personnel to contact the participant Exclusion Criteria for Cohort 1 and 2: * Any medical condition, treatment, or symptoms that, in the judgment of the trial clinician, could place the participant at more than the minimal risk from involvement in the testing. * Hospitalization, emergency room visit, surgery or new medical treatment within 30 days before testing begins or planned during testing. * Difficulty with or inability to swallow tablets. * Active skin infection or active dermatitis, or history of chronic inflammatory skin condition including psoriasis and chronic dermatitis (except atopic dermati…